GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Immunology market. Reports cover market growth forecasts, trends and research, and more.

Browse our full list of Immunology market reports here.

NEW Acute Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Acute Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Acute Inflammation pipeline landscape. The report provides comprehensive information on...

NEW Corneal Graft Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Corneal Graft Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Corneal Graft Rejection pipeline landscape. The report provides comprehensive...

NEW Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis)...

NEW Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Food Allergy pipeline landscape. The report provides comprehensive information on...

NEW Hematopoietic Stem Cell Transplantation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Hematopoietic Stem Cell Transplantation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Hematopoietic Stem Cell Transplantation pipeline landscape. The report...

NEW Chronic Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Chronic Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chronic Inflammation pipeline landscape. The report provides comprehensive information on...

NEW Lupus Nephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Lupus Nephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lupus Nephritis pipeline landscape. The report provides comprehensive information on...

NEW Pemphigus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Pemphigus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Pemphigus pipeline landscape. The report provides comprehensive information on the therapeutics...

NEW Plaque Psoriasis (Psoriasis Vulgaris) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,500
  • May 2022
Plaque Psoriasis (Psoriasis Vulgaris) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape. The report...

NEW Sarcoidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Sarcoidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Sarcoidosis pipeline landscape. The report provides comprehensive information on the therapeutics...